LOS ANGELES, Aug. 4, 2026 /PRNewswire/ -- Glancy Prongay Wolke & Rotter LLP announces that investors with losses have opportunity to lead the securities fraud class action lawsuit against PROCEPT BioRobotics Corporation.

IF YOU SUFFERED A LOSS ON YOUR PROCEPT BIOROBOTICS CORPORATION INVESTMENTS, CLICK HERE BEFORE SEPTEMBER 22, 2026 (LEAD PLAINTIFF DEADLINE) TO PARTICIPATE IN THE SECURITIES FRAUD LAWSUIT

What Is The Lawsuit About? 
The complaint filed in this class action alleges that between February 28, 2024 and February 25, 2026, Defendants made materially false and/or misleading statements regarding the Company's business, operations, and financial condition. Specifically, Defendants failed to disclose to investors that: (1) Procept used an extensive discount program designed to incentivize customers to place bulk handpiece orders in excess of procedure demand; (2) the undisclosed discount program artificially and unsustainably inflated Procept's reported U.S. handpiece unit sales and revenues by pulling forward sales at the expense of future periods; (3) the discount program caused customer handpiece orders to materially exceed underlying procedure demand throughout the Class Period, and this differential materially increased over time; (4) Procept's surplus of U.S. handpiece sales relative to procedures created excess field inventory and overstocking among its customers, totaling more than 10,000 excess units by the end of the Class Period; (5) as a result, Defendants materially overstated Procept's handpiece unit sales and the utilization of its field Systems; (6) Procept was exposed to undisclosed risks of significant operational and financial harm; and (7) as a result, Defendants' positive statements about the Company's business, operations, and prospects were materially misleading and/or lacked a reasonable basis at all relevant times.

What's The Next Step?
Glancy Prongay Wolke & Rotter LLP is a leading national shareholder rights law firm, ready to assist you in potentially pursuing claims to recover your loss.

If you wish to serve as lead plaintiff, you must move the Court no later than September 22, 2026. Please contact us to learn more about your rights and interests by clicking here, by email (shareholders@glancylaw.com), or by telephone at 310-201-9150 (Toll-Free: 888-773-9224).

You may retain counsel of your choice. If you bought securities during the class period, you may take no action and remain an absent class member. No class has been certified yet.

Why Glancy Prongay Wolke & Rotter LLP? 
GPWR is a premier law firm with decades of experience representing investors and consumers in securities litigation and other complex class action litigation. Recognizing the firm's recent successes, GPWR was named one of Law360's Securities Groups of the Year and ranked 2nd in total investor recoveries by Institutional Shareholder Services Securities Class Action Services in 2025. GPWR's lawyers have handled cases covering a wide spectrum of corporate misconduct and relating to nearly all industries and sectors. GPWR's past successes have been widely covered by leading news and industry publications such as The Wall Street Journal, The Financial Times, Bloomberg Businessweek, Reuters, the Associated Press, Barron's, Investor's Business Daily, Forbes, and Money. Prior results do not guarantee a similar outcome.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.

Contact Us: 
Glancy Prongay Wolke & Rotter LLP,  
1925 Century Park East, Suite 2100,
Los Angeles, CA 90067
Charles Linehan
Email:  shareholders@glancylaw.com
Telephone: 310-201-9150
Toll-Free: 888-773-9224
Visit our website at: www.glancylaw.com.

View original content to download multimedia:https://www.prnewswire.com/news-releases/procept-biorobotics-corporation-prct-shareholders-who-lost-money-have-opportunity-to-lead-securities-fraud-lawsuit-302842894.html

SOURCE Glancy Prongay Wolke & Rotter LLP